Therapeutic options in advanced laryngeal cancer: An overview

被引:11
作者
Dias, FL [1 ]
Lima, RA
Kligerman, J
Cernea, CR
机构
[1] Inst Nacl Canc, Dept Head & Neck Surg, INCA, Head & Neck Surg Serv, BR-20230130 Rio De Janeiro, Brazil
[2] Univ Sao Paulo, Fac Med, Dept Head & Neck Surg, Sao Paulo, Brazil
来源
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES | 2005年 / 67卷 / 06期
关键词
larynx; cancer; treatment; surgery; radiotherapy;
D O I
10.1159/000090040
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Historically, patients with advanced laryngeal cancer have been treated with radical surgery and adjuvant radiation therapy. Intensive surgical research has allowed surgeons to deal with almost any local extension and to propose an appropriate surgical procedure for each case. Several function-sparing surgical options are available to treat moderately advanced/ advanced laryngeal cancer. Better understanding of the anatomy and biology of cancer in this anatomical site has enabled us to devise effective oncological strategies associated with a great effort to preserve laryngeal function. Numerous efforts have been made to augment the therapeutic armamentarium with the addition of chemotherapeutic agents combined with radiation therapy. For advanced laryngeal cancer, the debate is still open between partial/subtotal surgical procedures, which are more efficient but sacrifice parts of the larynx, and radiotherapy/chemoradiation protocols which can preserve the larynx and its function even though it requires radical surgery for salvage. Efforts should be made to select patients properly, in an individual basis, based on tumor characteristics, clinical aspects, patient's expectations, and the expertise of the head and neck oncologic team for the various therapeutic strategies in order to get better oncological results in association with the preservation of the laryngeal form and function, when possible. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:311 / 318
页数:8
相关论文
共 69 条
  • [11] DAVIS RK, 1983, LARYNGOSCOPE, V93, P429
  • [12] DAVIS RK, 1991, LARYNGOSCOPE, V101, P680
  • [13] de Vincentiis M, 1998, HEAD NECK-J SCI SPEC, V20, P504, DOI 10.1002/(SICI)1097-0347(199809)20:6<504::AID-HED3>3.0.CO
  • [14] 2-T
  • [15] DESANTO LW, 1984, LARYNGOSCOPE, V94, P1311
  • [16] DIAS FL, 2000, 5 INT C HEAD NECK CA, V1
  • [17] Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials
    ElSayed, S
    Nelson, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 838 - 847
  • [18] Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
    Forastiere, AA
    Goepfert, H
    Maor, M
    Pajak, TF
    Weber, R
    Morrison, W
    Glisson, B
    Trotti, A
    Ridge, JA
    Chao, C
    Peters, G
    Lee, DJ
    Leaf, A
    Ensley, J
    Cooper, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) : 2091 - 2098
  • [19] SUPRAGLOTTIC LARYNGEAL CARCINOMA
    HARWOOD, AR
    HILL, RP
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (11): : 1759 - 1760
  • [20] MANAGEMENT OF ADVANCED GLOTTIC CANCER - 10-YEAR-REVIEW OF THE TORONTO EXPERIENCE
    HARWOOD, AR
    HAWKINS, NV
    BEALE, FA
    RIDER, WD
    BRYCE, DP
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (06): : 899 - 904